38 -6 (68) 2024 - Sultanov A.A., Xaitov Q.N. - TREATMENT OF CUTANEOUS LEISHMANIASIS AND IMPROVEMENT OF ITS PREVENTIVE MEASURES

TREATMENT OF CUTANEOUS LEISHMANIASIS AND IMPROVEMENT OF ITS PREVENTIVE MEASURES

Sultanov A.A. - Tashkent Medical Academy

Xaitov Q.N. - Tashkent Pediatric Medical Institute

Resume

According to statistics of cutaneous leishmaniasis, approximately 700,000 to 1 million new cases of the disease are recorded each year. The article presents the main directions of measures to prevent the spread of the disease and fight against it, as well as the indicators of the increase of cutaneous leishmaniasis in recent years.

Key words: cutaneous leishmaniasis, medical care, epidemic, prevention, carrier

First page

211

Last page

215

For citation:Sultanov A.A., Xaitov Q.N. - TREATMENT OF CUTANEOUS LEISHMANIASIS AND IMPROVEMENT OF ITS PREVENTIVE MEASURES//New Day in Medicine 6(68)2024 211-215 https://newdayworldmedicine.com/en/article/3758

List of References

  1. Абидова З.М. Рахматов А.Б., Рахимов И.Р. Кожный лейшманиоз / З.М. Абидова и др. - Ташкент: «Niso poligraf», 2019; 192 стр.
  2. Звонарева Е.В. Кожный лейшманиоз. //Научно-практический рецензируемый журнал «Здравоохранение Дальнего Востока» 2020 июнь; 2(72):55.
  3. Мустанов Ж.А., Миртазаев О.М., Матназарова Г.С., Расулов Ш.М. /Сурхондарё вилоятида лейшманиоз касаллигининг эпидемиологик тахлили. //Инфекция, иммунитет и фармакология, Ташкент 2019;1:126-132.
  4. Мустанов Ж.А., Миртазаев О.М., Матназарова Г.С., Расулов Ш.М. /Узбекистонда лейшманиоз касаллигининг эпидемиологик тахлили //Вестник Ташкент. 2020;4:109-113.
  5. Мустанов Ж.А., Расулов Ш.М. Сурхондарё вилоятида лейшманиоз касаллигининг таркалганлиги. // Биология ва тиббиёт муаммолари. 2019;3(103):122.
  6. Покровский В.И., Пак С.Г., Брико Н.И., Данилкин Б.К. Учебник - М.: ГЭОТАР-Медиа, 2021; 626-632.
  7. Ташбаев Н.С. Современная эпидемиологическая характеристика зоонозного кожного лейшманиоза и усовершенствование профилактических мероприятий. /Диссертация канд.мед.наук. - Ташкент, 2021; 5 - 103 с.
  8. Черкасский Б. А. Лейшманиоз. / Сб. Завозные болезни. 1979; 41-42.
  9. Adegboye O.A., Adegboye M. Spatially Correlated Time Series and Ecological Niche Analysis of Cutaneous Leishmaniasis in Afghanistan. // Int J Environ Res Public Health. 2022 Mar 17;14(3).
  10. Assis TSM, Rabello A, Werneck GL. Latent class analysis of diagnostic tests for visceral leishmaniasis in Brazil. //Trop. Med. Int. Health 2022; 17(10):1202-7.
  11. Boelaert M, Bhattacharya S, Chappuis F, El Safi S, Hailu A, Mondai D, et aL. Evaluation of rapid diagnostic tests: Visceral leishmaniasis. //Nat. Rev. Microbiol. 2007; 5:30-6.
  12. Galai Y, Chabchoub N, Ben-Abid M, Ben-Abda I, Ben-Alaya-Bouafif N, Amri F, et al. Diagnosis of Mediterranean visceral leishmaniasis by detection of Leishmania antibodies and Leishmania DNA in oral fluid samples collected using an oracol device. //J. Clin. Microbiol. 2011; 49(9):3150-3.
  13. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling R, et al. Visceral leishmaniasis: What are the needs for diagnosis, treatment and control? //Nat. Rev. Microbiol. 2020; 5(11):873-82.
  14. Dakic Z, Pelemis M, Stevanovic G, Poluga J, Lavadinovic L, Milosevic I, et al. Epidemiology and diagnosis of visceral leishmaniasis in Serbia. //Clin. Microbiol. Infect. 2019; 15(12):1173-6.
  15. Iqbal J, Hira P, Saroj G, Philip R, Al-Ali F, Madda P, et al. Imported visceral leishmaniasis: Comparative analysis of three assays. //J. Clin. Microbiol. 2002; 40(2):475-9.
  16. Kohanteb J, Ardehali S. Cross-reaction of sera from patients with various infectious diseases with Leishmania infantum. //Med. Princ. Pract. 2005; 14(2):79-82.
  17. Mohammad Akhoundi M, Tim Downing T, Jan Voiÿpka J, et al. Leishmania infections: Molecular targets and diagnosis. //Mol. Aspects Med. 2019. Jan 31.
  18. Riera C, Fisa R, Lopez P, Ribera E, Carrio J, Falco V, et al. Evaluation of a latex agglutination test (KAtex) for detection of Leishmania antigen in urine of patients with HIV-Leishmania coinfection: Value in diagnosis and post-treatment follow-up. //Eur. J. Clin. MicrobioL Infect. Dis. 2023;(12):899-904.
  19. Sakkas H, Gartzonika C, Levidiotou S. Laboratory diagnosis of human visceral leishmaniasis. //J. Vector Borne Dis. 2021 March; 53: 8-16.
  20. Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: a review. // F1000Research. 2023;6:750.

    file

    download